For The Better

Uranium prices are up but not enough for these companies to earn a profit.

Qualcomm and other peers have spoken out against the takeover in recent months.

The company reported great results from an early-stage study of its experimental atopic dermatitis drug.

The WallStreetBets crowd continues to drive up volatility on a variety of stocks.

The FDA refused to approve IV tramadol for the second time.

These companies make good long-term core holdings.

Blue Origin’s space tourism auction set a record.

P&G and two other solid income stocks should generate reliable long-term gains.

When the chips are down this is where to place your bets.

This under-the-radar edge computing stock has more than meets the eye.

Activist pressure and a court order have the oil giant exploring alternatives.

Like most crypto stocks, Diginex seems to be benefiting from some upbeat news for Bitcoin.

Why long-term investors should still stay away from this movie theater chain.

A tweet by Elon Musk over the weekend helped Bitcoin’s price rise — and MicroStrategy’s share price along with it.

Short-seller Hindenburg Research strikes again.

The luxury furniture niche is still booming, and it might have a long growth runway ahead.

The company’s quarterly financial update was disappointing, but management sees a bright future.

“Cheap” is not the same as “bad.” These high-quality companies are just fantastic buys right now.